Source:http://linkedlifedata.com/resource/pubmed/id/11733706
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
2001-12-4
|
pubmed:abstractText |
The role of brain amines in mediating the effects of the wake-promoting agent modafinil, used in the treatment of sleepiness associated with narcolepsy is still uncertain. Therefore we studied the effects of modafinil on extracellular serotonin (5-HT), dopamine (DA) and noradrenaline (NA), in rat prefrontal cortex and in the medial hypothalamus area. Modafinil (128 mg/kg i.p.) significantly increased waking in the first 4 h of EEG sleep recording. This cortical and behavioral activation was associated with an initial increase in extracellular 5-HT, DA and NA during the first 60 min following modafinil administration. In the prefrontal cortex, 5-HT release remained high for 3 h after modafinil administration. In contrast, in the hypothalamus, only NA release was enhanced while DA and 5-HT levels remained low. In a first step, modafinil may generate waking partly via cortical monoamine release, particularly DA and 5-HT, and also hypothalamic NA. In a second step, maintenance of waking might depend on hypothalamic NA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzhydryl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Biogenic Monoamines,
http://linkedlifedata.com/resource/pubmed/chemical/Central Nervous System Stimulants,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/modafinil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0959-4965
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3533-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11733706-Animals,
pubmed-meshheading:11733706-Benzhydryl Compounds,
pubmed-meshheading:11733706-Biogenic Monoamines,
pubmed-meshheading:11733706-Central Nervous System Stimulants,
pubmed-meshheading:11733706-Dopamine,
pubmed-meshheading:11733706-Extracellular Space,
pubmed-meshheading:11733706-Hypothalamus, Middle,
pubmed-meshheading:11733706-Injections, Intraperitoneal,
pubmed-meshheading:11733706-Male,
pubmed-meshheading:11733706-Microdialysis,
pubmed-meshheading:11733706-Norepinephrine,
pubmed-meshheading:11733706-Prefrontal Cortex,
pubmed-meshheading:11733706-Rats,
pubmed-meshheading:11733706-Rats, Wistar,
pubmed-meshheading:11733706-Serotonin
|
pubmed:year |
2001
|
pubmed:articleTitle |
Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats.
|
pubmed:affiliation |
Division of Adult Psychiatry, Sleep Laboratory, University Hospital of Geneva (HUG), 2 Chemin du Petit Bel Air, CH-1225 Chêne-Bourg, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|